191 related articles for article (PubMed ID: 26857527)
1. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
[TBL] [Abstract][Full Text] [Related]
2. Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.
Thomas NE; Edmiston SN; Orlow I; Kanetsky PA; Luo L; Gibbs DC; Parrish EA; Hao H; Busam KJ; Armstrong BK; Kricker A; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Ollila DW; Begg CB; Berwick M; Conway K;
J Invest Dermatol; 2018 Nov; 138(11):2398-2404. PubMed ID: 29753029
[TBL] [Abstract][Full Text] [Related]
3. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis.
Lee EY; Williamson R; Watt P; Hughes MC; Green AC; Whiteman DC
Int J Cancer; 2006 Aug; 119(3):636-42. PubMed ID: 16572428
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.
Peña-Chilet M; Blanquer-Maceiras M; Ibarrola-Villava M; Martinez-Cadenas C; Martin-Gonzalez M; Gomez-Fernandez C; Mayor M; Aviles JA; Lluch A; Ribas G
BMC Cancer; 2013 Mar; 13():160. PubMed ID: 23537197
[TBL] [Abstract][Full Text] [Related]
6. Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.
Gibbs DC; Ward SV; Orlow I; Cadby G; Kanetsky PA; Luo L; Busam KJ; Kricker A; Armstrong BK; Cust AE; Anton-Culver H; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Ollila DW; Begg CB; Berwick M; Thomas NE;
Br J Dermatol; 2017 Nov; 177(5):e180-e182. PubMed ID: 28667740
[No Abstract] [Full Text] [Related]
7. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
[TBL] [Abstract][Full Text] [Related]
8. IRF4 rs12203592 functional variant and melanoma survival.
Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
[TBL] [Abstract][Full Text] [Related]
9. Association of interferon regulatory factor 4 gene polymorphisms rs12203592 and rs872071 with skin cancer and haematological malignancies susceptibility: a meta-analysis of 19 case-control studies.
Wang S; Yan Q; Chen P; Zhao P; Gu A
BMC Cancer; 2014 Jun; 14():410. PubMed ID: 24906573
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the Correlation Between Interleukin-6 Promoter Polymorphism -174G/C and Interferon Regulatory Factor 4 rs12203592 Polymorphism With Skin Cancer Susceptibility.
Wu M; Cao Y; Liu YL; Ma LL; Yang XH
Am J Ther; 2016; 23(6):e1758-e1767. PubMed ID: 26928068
[TBL] [Abstract][Full Text] [Related]
11. Solar elastosis and cutaneous melanoma: a site-specific analysis.
Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
Int J Cancer; 2015 Jun; 136(12):2900-11. PubMed ID: 25403328
[TBL] [Abstract][Full Text] [Related]
12. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
[TBL] [Abstract][Full Text] [Related]
13. Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.
Ward SV; Gibbs DC; Orlow I; Thomas NE; Kanetsky PA; Luo L; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Rosso S; Zanetti R; Dwyer T; Begg CB; Berwick M;
Br J Dermatol; 2020 Jul; 183(1):163-165. PubMed ID: 31958143
[No Abstract] [Full Text] [Related]
14. IRF4 rs12203592*T/T genotype is associated with nodular melanoma.
Rayner JE; McMeniman EK; Duffy DL; De'Ambrosis B; Smithers BM; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
Melanoma Res; 2019 Aug; 29(4):445-446. PubMed ID: 31246726
[No Abstract] [Full Text] [Related]
15. Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
Zhang T; Choi J; Dilshat R; Einarsdóttir BÓ; Kovacs MA; Xu M; Malasky M; Chowdhury S; Jones K; Bishop DT; Goldstein AM; Iles MM; Landi MT; Law MH; Shi J; Steingrímsson E; Brown KM
Am J Hum Genet; 2021 Sep; 108(9):1631-1646. PubMed ID: 34293285
[TBL] [Abstract][Full Text] [Related]
16. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
[TBL] [Abstract][Full Text] [Related]
17. Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis.
Thomas NE; Kricker A; From L; Busam K; Millikan RC; Ritchey ME; Armstrong BK; Lee-Taylor J; Marrett LD; Anton-Culver H; Zanetti R; Rosso S; Gallagher RP; Dwyer T; Goumas C; Kanetsky PA; Begg CB; Orlow I; Wilcox H; Paine S; Berwick M;
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2932-41. PubMed ID: 20802019
[TBL] [Abstract][Full Text] [Related]
18. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
Laino AM; Berry EG; Jagirdar K; Lee KJ; Duffy DL; Soyer HP; Sturm RA
Br J Dermatol; 2018 May; 178(5):1119-1127. PubMed ID: 29315480
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells.
Chhabra Y; Yong HXL; Fane ME; Soogrim A; Lim W; Mahiuddin DN; Kim RSQ; Ashcroft M; Beatson SA; Ainger SA; Smit DJ; Jagirdar K; Walker GJ; Sturm RA; Smith AG
Pigment Cell Melanoma Res; 2018 Jan; 31(1):51-63. PubMed ID: 28755520
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.
Visser M; Palstra RJ; Kayser M
Hum Mol Genet; 2015 May; 24(9):2649-61. PubMed ID: 25631878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]